Zhejiang Wecome Pharmaceutical Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of 300878?
Owner Type	Number of Shares	Ownership Percentage
Institutions	2,249,521	1.58%
Private Companies	5,923,215	4.17%
General Public	34,200,245	24.1%
Individual Insiders	99,678,315	70.2%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Top Shareholders

Top 19 shareholders own 75.92% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
69%	Zhongliang Liu	98,032,430	CN¥1.7b	0%	no data
4.17%	Lishui Shunze Investment Management Partnership Enterprise (Limited Partnership)	5,923,215	CN¥103.5m	0%	no data
0.63%	Xiaoxia Kong	888,484	CN¥15.5m	0%	no data
0.59%	Golden Trust SinoPac Fund Management Co., Ltd.	835,048	CN¥14.6m	0%	0.14%
0.29%	Weifang Lu	409,220	CN¥7.1m	0%	no data
0.27%	Shanghai Guotai Junan Securities Asset Management Co., Ltd.	378,825	CN¥6.6m	0%	0.02%
0.25%	Dexiong Dai	348,181	CN¥6.1m	0%	no data
0.24%	Barclays PLC Private Banking & Investment Banking Investment	347,075	CN¥6.1m	0%	no data
0.23%	Morgan Stanley, Investment Banking and Brokerage Investments	327,087	CN¥5.7m	21%	no data
0.2%	UBS Asset Management AG	290,352	CN¥5.1m	0%	no data
0.018%	Xin Yuan Asset Management Company	26,100	CN¥455.9k	0%	0.03%
0.017%	Wanjia Asset Management Co., Ltd.	24,500	CN¥428.1k	0%	no data
0.0091%	China Asset Management Co. Ltd.	12,900	CN¥225.3k	0%	no data
0.0018%	Manulife Asset Management	2,600	CN¥45.4k	0%	no data
0.0017%	GF Fund Management Co., Ltd.	2,400	CN¥41.9k	0%	no data
0.0008%	Lion Fund Management Co. Ltd.	1,134	CN¥19.9k	0%	no data
0.00056%	China Universal Asset Management Company Ltd.	800	CN¥13.9k	0%	no data
0.00028%	Harvest Fund Management Co. Ltd.	400	CN¥6.9k	0%	no data
0.00021%	Guotai Asset Management Company Limited	300	CN¥5.2k	0%	no data

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2024/12/24 02:35
End of Day Share Price	2024/12/24 00:00
Earnings	2024/09/30
Annual Earnings	2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Zhejiang Wecome Pharmaceutical Company Limited is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Analyst	Institution